The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement
Authors:
- Giuseppe LippiGLGiuseppe Lippi
- Massimo FranchiniMFMassimo Franchini
- Giovanni TargherGTGiovanni Targher
- Giovanni PoliGPGiovanni Poli
- Gian Cesare GuidiGGGian Cesare Guidi
- 1 June 2007
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 381 (2) , 167-170
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Recent acquisitions in acquired and congenital von Willebrand disordersClinica Chimica Acta, 2007
- Aspects of the Laboratory Identification of von Willebrand Disease in WomenSeminars in Thrombosis and Hemostasis, 2006
- von Willebrand factor, endothelial dysfunction, and cardiovascular diseaseJournal of Thrombosis and Haemostasis, 2006
- Insights into von Willebrand factor proteolysis: clinical implicationsBritish Journal of Haematology, 2006
- Von Willebrand factor and thrombosisAnnals of Hematology, 2006
- Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and womenThrombosis and Haemostasis, 2006
- Plasma von Willebrand factor, thrombosis, and the endothelium: The first 30 yearsThrombosis and Haemostasis, 2006
- Effects of inflammatory cytokines on the release and cleavage of the endothelial cell–derived ultralarge von Willebrand factor multimers under flowBlood, 2004
- von Willebrand factor and coronary heart disease. Prospective study and meta-analysisEuropean Heart Journal, 2002
- Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatmentVascular Pharmacology, 2002